Business Summary
Rege Nephro Co Ltd is a Japan-based company mainly engaged in the research, development, production and sale of therapeutic drugs for renal diseases. The Company is engaged in the creation of renal progenitor cells from production of induced pluripotent stem (iPS) cells by inducing differentiation. The iPS cell-derived renal progenitor cells have been shown to improve renal damage in animal experiments. The Company is engaged in the practical application of cell medicines containing iPS cell-derived renal progenitor cells as an active ingredient.
Country of Incorporation
Japan
Incorporation Date
2019-09-20
Business Sector
Pharmaceuticals & Medical Research
Company Address
Med-Pharm Collaboration Bldg., Kyoto University, 46-29, Yoshidashimoadachi-cho, Sakyo-ku